Ravikumar, L, et al. “Dapagliflozin and Sitagliptin Combination Therapy: An Overview of Clinical Utility in Type 2 Diabetes Mellitus With Multiple Cardiovascular Risk Factors”. Cardiology and Cardiovascular Medicine, vol. 7, no. 2, Apr. 2023, pp. 141-4, http://www.fortunejournals.org/ojs/index.php/ccm/article/view/16403.